Literature DB >> 11254711

Cysteinylation of MHC class II ligands: peptide endocytosis and reduction within APC influences T cell recognition.

M A Haque1, J W Hawes, J S Blum.   

Abstract

Peptides bind cell surface MHC class II proteins to yield complexes capable of activating CD4(+) T cells. By contrast, protein Ags require internalization and processing by APC before functional presentation. Here, T cell recognition of a short peptide in the context of class II proteins occurred only after delivery of this ligand to mature endosomal/lysosomal compartments within APC. Functional and biochemical studies revealed that a central cysteine within the peptide was cysteinylated, perturbing T cell recognition of this epitope. Internalization and processing of the modified epitope by APC, was required to restore T cell recognition. Peptide cysteinylation and reduction could occur rapidly and reversibly before MHC binding. Cysteinylation did not disrupt peptide binding to class II molecules, rather the modified peptide displayed an enhanced affinity for MHC at neutral pH. However, once the peptide was bound to class II proteins, oxidation or reduction of cysteine residues was severely limited. Cysteinylation has been shown to radically influence T cell responses to MHC class I ligands. The ability of professional APC to reductively cleave this peptide modification presumably evolved to circumvent a similar problem in MHC class II ligand recognition.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11254711     DOI: 10.4049/jimmunol.166.7.4543

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

1.  The Dendritic Cell Major Histocompatibility Complex II (MHC II) Peptidome Derives from a Variety of Processing Pathways and Includes Peptides with a Broad Spectrum of HLA-DM Sensitivity.

Authors:  Cristina C Clement; Aniuska Becerra; Liusong Yin; Valerio Zolla; Liling Huang; Simone Merlin; Antonia Follenzi; Scott A Shaffer; Lawrence J Stern; Laura Santambrogio
Journal:  J Biol Chem       Date:  2016-01-06       Impact factor: 5.157

Review 2.  Emerging role of combination of all-trans retinoic acid and interferon-gamma as chemoimmunotherapy in the management of human glioblastoma.

Authors:  Azizul Haque; Naren L Banik; Swapan K Ray
Journal:  Neurochem Res       Date:  2007-08-04       Impact factor: 3.996

3.  Invariant chain modulates HLA class II protein recycling and peptide presentation in nonprofessional antigen presenting cells.

Authors:  Azizul Haque; Laela M Hajiaghamohseni; Ping Li; Katherine Toomy; Janice S Blum
Journal:  Cell Immunol       Date:  2007-12-11       Impact factor: 4.868

Review 4.  Post-translationally modified T cell epitopes: immune recognition and immunotherapy.

Authors:  Jan Petersen; Anthony W Purcell; Jamie Rossjohn
Journal:  J Mol Med (Berl)       Date:  2009-09-08       Impact factor: 4.599

5.  Disruption of HLA class II antigen presentation in Burkitt lymphoma: implication of a 47,000 MW acid labile protein in CD4+ T-cell recognition.

Authors:  Jason M God; Dan Zhao; Christine A Cameron; Shereen Amria; Jennifer R Bethard; Azizul Haque
Journal:  Immunology       Date:  2014-07       Impact factor: 7.397

6.  Reduction of myeloid-derived suppressor cells and lymphoma growth by a natural triterpenoid.

Authors:  Faisal F Y Radwan; Azim Hossain; Jason M God; Nathan Leaphart; Michelle Elvington; Mitzi Nagarkatti; Stephen Tomlinson; Azizul Haque
Journal:  J Cell Biochem       Date:  2015-01       Impact factor: 4.429

Review 7.  The melting pot of the MHC II peptidome.

Authors:  Lawrence J Stern; Laura Santambrogio
Journal:  Curr Opin Immunol       Date:  2016-03-25       Impact factor: 7.486

8.  A possible cross-talk between autophagy and apoptosis in generating an immune response in melanoma.

Authors:  Azim Hossain; Faisal F Y Radwan; Bently P Doonan; Jason M God; Lixia Zhang; P Darwin Bell; Azizul Haque
Journal:  Apoptosis       Date:  2012-10       Impact factor: 4.677

9.  Gamma-IFN-inducible-lysosomal thiol reductase modulates acidic proteases and HLA class II antigen processing in melanoma.

Authors:  Oliver G Goldstein; Laela M Hajiaghamohseni; Shereen Amria; Kumaran Sundaram; Sakamuri V Reddy; Azizul Haque
Journal:  Cancer Immunol Immunother       Date:  2008-03-15       Impact factor: 6.968

10.  Insights into the Role of GILT in HLA Class II Antigen Processing and Presentation by Melanoma.

Authors:  Duncan L Norton; Azizul Haque
Journal:  J Oncol       Date:  2009-11-24       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.